Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Dementia or Alzheimer's : a simple test could differentiate them

Published on: 22/01/2016 Reading time: 1 min
image

Patients with fronto-temporal dementia need specific and appropriate medical care. However, this disease is still too often confused with Alzheimer's disease. Clinicians and researchers from Paris Brain Institute and from the Memory and Alzheimer's Disease Institute (IM2A), in collaboration with an international team, have just demonstrated that simple tests evaluating empathy could guide the diagnosis.

Alzheimer's or frontotemporal dementia ? Not so easy to differenciate. Frontotemporal Dementia (FTD) comes indeed in three clinical forms, the most common –the so-called frontal or behavioural variant(fv)- causes  memory disorders. This often overlooked fact tends to diagnose some patients with Alzheimer's disease by mistake. But this could change soon : Maxime Bertoux (unit 975 Inserm/CNRS/Pierre and Marie Curie University, Brain and Spine Institute, Paris), in collaboration with an international team, has shown that the social cognition assessment could be an efficient tool to distinguish both diseases : "social cognition is the set of cognitive abilities enabling someone to adapt to his social environment," explains the researcher.

Researchers used two tests for their study : one is to ask the patient to recognize emotions in frontal face pictures ; in the second, the "stumble" test, life scenes are described to the patient, who has to figure out those who are, or are not socially embarrassing. The goal was to evaluate whether these two combined tests are relevant for differentiating  patients with FTDfV from those with Alzheimer's disease.

Researchers retrospectively analyzed the record of 96 patients received at the cognitive and behavioural disease Centre in the Pitié-Salpêtrière hospital (Paris) and with one of the two diseases. All had received an initial check-up with imaging, cerebrospinal fluid analysis (CSF), memory tests and social cognition tests - the so-called mini-SEA tests (social cognition and emotional assessment). The analysis consisted in determining if the results of these last two examination types were consistent with the diagnosis selected by the medical team on the basis of the performed diagnostic tests results. "We found that 85 to 94% patients can be classified in the right group –Alzheimer's or FTDfv- relying solely on mini-SEA tests. Comparatively, the result is only 70% with only memory tests, which in practice means an inaccurate diagnosis of Alzheimer's disease in a FTD patient out of two ". A grey zone remained in 11% cases : "the tests fail to direct to either disease. The concerned patients are at an advanced stage, for whom cognitive impairment becomes more general ". In an early diagnosis situation, this problem does not usually exist.

A SIMPLE DIAGNOSTIC TEST TO INTEGRATE ROUTINELY

FTD accounts for 20% of degenerative dementias, and nearly one-third of cases diagnosed in patients under 65. If the frontal variant can be confused with Alzheimer's disease, it is often distinguished through personality disorders, a disruption of the sense of social values... which require well-specific medical and psychosocial care. "This study could therefore be useful to review the diagnostic criteria of both diseases," explains the researcher, and thus provide more appropriate support".

In the meantime, the authors of this study insist that " doctors and neuropsychologists should be aware of the fact that the distinction between Alzheimer's and FTD may not be based solely on memory tests : social cognition tests have here a crucial importance ". Quick and inexpensive, these could, in the medium term, be one of the reference diagnostic tests. "But to improve the precocity of the diagnosis of these diseases, identification of impaired neuronal and cognitive decline new markers is required." This is the challenge set by several authors, within a brand new research institute on  dementias, located within the East Anglia British university (Norwich, England).

Our news on the subject

02 December 2024
Visuel of Scientific lectures
Scientific lectures: Michael GREICIUS
Speaker : Michael GREICIUS, Stanford medicine health care. "Reaching for high-hanging fruit in Alzheimer’s disease genetics"
11.12.2024 Scientific lectures
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
See all our news